Alpa Laboratories (NSE:ALPA) Capital Expenditure: ₹0.00 Mil (TTM As of Mar. 2026)


NSE:ALPA Alpa Laboratories Ltd NSE:ALPA
76 GF Score
Price ₹67.66
GF Value ₹92.72
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Alpa Laboratories Capital Expenditure?

Alpa Laboratories NSE:ALPA +0.12% 76 Capital Expenditure is ₹0.00 Mil as of Mar. 2026. GuruFocus rates NSE:ALPA with a GF Score™ of 76/100 and a GF Value™ of ₹92.72 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Alpa Laboratories's cash flow for capital expenditures for the three months ended in Mar. 2026 was ₹0 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.00 Mil.

Alpa Laboratories Capital Expenditure Historical Data

* Premium members only.

The historical data trend for Alpa Laboratories's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpa Laboratories Capital Expenditure Chart

Alpa Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -21.91 -11.26 -63.85 -113.80 -39.54

Alpa Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:ALPA
76GF Score
Alpa Laboratories Ltd NSE:ALPA
Capital Expenditure is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpa Laboratories Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Capital Expenditure →
What does a Capital Expenditure of ₹0.00 Mil mean?
Alpa Laboratories (NSE:ALPA) has a Capital Expenditure of ₹0.00 Mil as of Mar. 2026. Capital Expenditures represent the company's purchases of property, plant, equipment and other long-term fixed assets. View historical data for Alpa Laboratories.
Is Alpa Laboratories' Capital Expenditure too high?
Alpa Laboratories' current Capital Expenditure is ₹0.00 Mil. Overall, Alpa Laboratories has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alpa Laboratories' Capital Expenditure compare to ZTS?
Alpa Laboratories' Capital Expenditure of ₹0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Capital Expenditure for a Drug Manufacturers company?
A good Capital Expenditure depends on the Drug Manufacturers industry context. However, Capital Expenditure should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Capital Expenditure mean?
A high Capital Expenditure can signal that a stock is expensive relative to its fundamentals. Capital Expenditures represent the company's purchases of property, plant, equipment and other long-term fixed assets. View historical data for Alpa Laboratories. Alpa Laboratories's current Capital Expenditure is ₹0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Alpa Laboratories (NSE:ALPA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹92.72, compared to a current price of ₹67.66 — trading 27% below its estimated fair value. The current Capital Expenditure is ₹0.00 Mil. Alpa Laboratories' overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Capital Expenditure calculated?
Capital Expenditure is calculated from a company's financial statements. For Alpa Laboratories (NSE:ALPA), the current Capital Expenditure is ₹0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alpa Laboratories (NSE:ALPA) Overvalued in 2026?

Based on GuruFocus' analysis, Alpa Laboratories stock appears to be undervalued. The current stock price of ₹67.66 is trading 27% below its estimated GF Value™ of ₹92.72. GuruFocus considers Alpa Laboratories to be Modestly Undervalued.

Key valuation signals for NSE:ALPA:

  • Capital Expenditure: ₹0.00 Mil
  • GF Value™: ₹92.72 vs. price of ₹67.66 (27% below fair value)
  • GF Score™: 76/100 with 6 warning signs

No single metric tells the full story. See the NSE:ALPA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alpa Laboratories Business Description

Other Exchanges 532878:India
Address 33/2, A.B. Road, Pigdamber, Rau, Indore, MP, IND, 453446
Alpa Laboratories Ltd is an India-based pharmaceutical company. It operates in the drug and chemical business segment. The company manufactures and markets pharmaceuticals and related products. It sells products like liquid injection, dry powder injection, tablets, capsules, and ointments.
76GF Score

Get the complete analysis for NSE:ALPA

Capital Expenditure is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹67.66
Price
₹92.72
GF Value